Risperidone and ethyl pyruvate have protective effects against ketamine-induced cognitive impairments in mice
İ. Kelle, H. Eriman, M. Erdinc, E. Uyar Department of Medical Pharmacology, Dicle University, Faculty of Medicine, Diyarbakir, Turkey. eczemreuyar@hotmail.com
OBJECTIVE: Ketamine, an N-methyl D-aspartic acid receptor antagonist drug, is reported to produce memory disruptions. The aim of this study was to investigate the protective effects of ethyl pyruvate (EP), a pyruvic acid derivative, and risperidone, an atypical antipsychotic drug, against ketamine-induced cognitive disturbances.
MATERIALS AND METHODS: A passive-avoidance test, a novel object recognition test, and a modified elevated plus maze test were used to assess memory functions. Hippocampal malondialdehyde (MDA) levels were measured to determine the oxidation levels.
RESULTS: Ketamine applications produced memory deficits in all tests and insignificantly increased MDA levels, which were alleviated by risperidone, EP, and combination treatments.
CONCLUSIONS: Increased oxidative stress and neurotransmission imbalance can be responsible for ketamine-induced memory disruptions. With its antioxidant effects, EP may be helpful to reduce cognitive impairments related to schizophrenia either alone or in combination with antipsychotics.
Free PDF Download![Creative Commons License](https://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
İ. Kelle, H. Eriman, M. Erdinc, E. Uyar
Risperidone and ethyl pyruvate have protective effects against ketamine-induced cognitive impairments in mice
Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 5
Pages: 1708-1716
DOI: 10.26355/eurrev_202203_28240